{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:57Z","timestamp":1786119177646,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/nmd.0b013e31817cf6f7","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T15:05:10Z","timestamp":1236265510000},"page":"548-555","source":"Crossref","is-referenced-by-count":11,"title":["Relapse Following Combined Treatment Discontinuation in a Placebo-Controlled Trial for Panic Disorder"],"prefix":"10.1097","volume":"196","author":[{"given":"Susan D.","family":"Raffa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill A.","family":"Stoddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila S.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack M.","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Katherine","family":"Shear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott W.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210208","article-title":"Mastery of Your Anxiety and Panic, II.","author":"Barlow","year":"1994"},{"key":"R2-5-20210208","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/jama.283.19.2529","article-title":"Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.","volume":"283","author":"Barlow","year":"2000","journal-title":"JAMA"},{"key":"R3-5-20210208","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1192\/bjp.164.5.652","article-title":"Alprazolam and exposure for panic disorder with agoraphobia attribution of improvement to medication predicts subsequent relapse.","volume":"164","author":"Basoglu","year":"1994","journal-title":"Br J Psychiatry"},{"key":"R4-5-20210208","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000068687","article-title":"Attribution of improvement to medication and increased risk of relapse of panic disorder with agoraphobia.","volume":"72","author":"Biondi","year":"2003","journal-title":"Psychother Psychosom"},{"key":"R5-5-20210208","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0165-0327(86)90050-9","article-title":"A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both.","volume":"10","author":"Blackburn","year":"1986","journal-title":"J Affect Disord"},{"key":"R6-5-20210208","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0006-3223(02)01546-9","article-title":"Context, ambiguity and unlearning: Sources of relapse after behavioral extinction.","volume":"52","author":"Bouton","year":"2002","journal-title":"Biol Psychiatry"},{"key":"R7-5-20210208","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1037\/0033-295X.108.1.4","article-title":"A modern learning-theory perspective on the etiology of panic disorder.","volume":"108","author":"Bouton","year":"2001","journal-title":"Psychol Rev"},{"key":"R8-5-20210208","article-title":"Attributions and Psychological Change.","author":"Brewin","year":"1982"},{"key":"R9-5-20210208","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1037\/0022-006X.63.5.754","article-title":"Long-term outcome in cognitive-behavioral treatment of panic disorder: Clinical predictors and alternative strategies for assessment.","volume":"63","author":"Brown","year":"1995","journal-title":"J Consult Clin Psychol"},{"key":"R10-5-20210208","article-title":"Integrating Pharmacotherapy and Psychotherapy (pp 105\u2013118).","author":"Chiles","year":"1991"},{"key":"R11-5-20210208","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1037\/h0034965","article-title":"Attribution and the maintenance of behavior change in falling asleep.","volume":"82","author":"Davison","year":"1973","journal-title":"J Abnorm Psychol"},{"key":"R12-5-20210208","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archpsyc.1992.01820100046009","article-title":"Differential relapse rates following cognitive therapy and pharmacotherapy for depression.","volume":"49","author":"Evans","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"R13-5-20210208","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005053-199306000-00002","article-title":"How sound is the double blind strategy for evaluating psychotropic drugs?","volume":"181","author":"Fisher","year":"1993","journal-title":"J Nerv Ment Dis"},{"key":"R14-5-20210208","article-title":"ECDEU Assessment Manual for Psychopharmacology-Revised.","author":"Guy","year":"1976"},{"key":"R15-5-20210208","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1192\/bjp.182.4.312","article-title":"Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial.","volume":"182","author":"Haug","year":"2003","journal-title":"Br J Psychiatry"},{"key":"R16-5-20210208","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/(SICI)1522-7154(1996)2:1<34::AID-ANXI5>3.0.CO;2-D","article-title":"Anxiety sensitivity and treatment outcome in panic disorder.","volume":"2","author":"Hazen","year":"1996","journal-title":"Anxiety"},{"key":"R17-5-20210208","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1176\/ajp.155.1.43","article-title":"Pretreatment attrition in a comparative treatment outcome study on panic disorder.","volume":"155","author":"Hofmann","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R18-5-20210208","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev.psych.57.102904.190044","article-title":"Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety.","volume":"57","author":"Hollon","year":"2006","journal-title":"Annu Rev Psychol"},{"key":"R19-5-20210208","first-page":"138","article-title":"Blindness and the validity of the double-blind procedure.","volume":"5","author":"Hughes","year":"1985","journal-title":"J Clin Pharmacol"},{"key":"R20-5-20210208","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM200005183422001","article-title":"A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy and their combination for the treatment of chronic depression.","volume":"342","author":"Keller","year":"2000","journal-title":"N Engl J Med"},{"key":"R21-5-20210208","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1192\/bjp.174.3.205","article-title":"Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia.","volume":"174","author":"Loerch","year":"1999","journal-title":"Br J Psychiatry"},{"key":"R22-5-20210208","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1037\/0022-006X.59.1.184","article-title":"How \u201cblind\u201d are double-blind studies?","volume":"59","author":"Margraf","year":"1991","journal-title":"J Consult Clin Psychol"},{"key":"R23-5-20210208","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1192\/bjp.162.6.776","article-title":"Alprazolam and exposure alone and combined in panic disorder with agoraphobia: A controlled study in London and Toronto.","volume":"162","author":"Marks","year":"1993","journal-title":"Br J Psychiatry"},{"key":"R24-5-20210208","article-title":"A Guide to Treatments That Work (3rd ed).","year":"2002"},{"key":"R25-5-20210208","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1017\/S1092852900020526","article-title":"Clinical perspectives on the combination of D-cycloserine and cognitive-behavioral therapy for the treatment of anxiety disorders.","volume":"12","author":"Otto","year":"2007","journal-title":"CNS Spectr"},{"key":"R26-5-20210208","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/1381612023396726","article-title":"Benzodiazepine discontinuation difficulties in panic disorder: Conceptual model and outcome for cognitive-behavior therapy.","volume":"8","author":"Otto","year":"2002","journal-title":"Curr Pharm Des"},{"key":"R27-5-20210208","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0005-7894(96)80028-1","article-title":"Maintenance of remission following cognitive behavior therapy for panic disorder: Possible deleterious effects of concurrent medication treatment.","volume":"27","author":"Otto","year":"1996","journal-title":"Behav Ther"},{"key":"R28-5-20210208","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1176\/ajp.150.10.1485","article-title":"Discontinuation of benzodiazepine treatment: Efficacy of cognitive-behavioral therapy for patients with panic disorder.","volume":"150","author":"Otto","year":"1993","journal-title":"Am J Psychiatry"},{"key":"R29-5-20210208","first-page":"72","article-title":"Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: Review and analysis.","volume":"12","author":"Otto","year":"2005","journal-title":"Clinical Psychology: Science & Practice"},{"key":"R30-5-20210208","article-title":"Anxiety Sensitivity Index Revised Test Manual.","author":"Peterson","year":"1993"},{"key":"R32-5-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-7967(86)90143-9","article-title":"Anxiety sensitivity, anxiety frequency and the prediction of fearfulness.","volume":"24","author":"Reiss","year":"1986","journal-title":"Behav Res Ther"},{"key":"R33-5-20210208","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/sj.npp.1300373","article-title":"Independent evaluator knowledge of treatment in a multicenter comparative treatment study of panic disorder.","volume":"29","author":"Roll","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"R34-5-20210208","doi-asserted-by":"crossref","DOI":"10.1037\/10415-000","article-title":"Combined Treatments for Mental Disorders: A Guide to Psychological and Pharmacological Interventions.","author":"Sammons","year":"2001"},{"key":"R35-5-20210208","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archpsyc.62.5.513","article-title":"Chronic depression: Medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.","volume":"62","author":"Schatzberg","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"R36-5-20210208","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0887-6185(96)00008-4","article-title":"Fluvoxamine, placebo and cognitive behavior therapy used alone and in combination in the treatment of panic disorder and agoraphobia.","volume":"10","author":"Sharp","year":"1996","journal-title":"J Anxiety Disord"},{"key":"R37-5-20210208","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1176\/ajp.154.11.1571","article-title":"Multicenter collaborative panic disorder severity scale.","volume":"154","author":"Shear","year":"1997","journal-title":"Am J Psychiatry"},{"key":"R38-5-20210208","article-title":"Panic Disorder Severity Scale (PDSS).","author":"Shear","year":"1992"},{"key":"R39-5-20210208","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archpsyc.1986.01800010045006","article-title":"Cognitive therapy and pharmacotherapy for depression: Sustained improvement over one year.","volume":"43","author":"Simons","year":"1986","journal-title":"Arch Gen Psychiatry"},{"key":"R40-5-20210208","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF01184454","article-title":"The effect of treatment attributions on the maintenance of weight reduction: A replication and extension.","volume":"3","author":"Sonne","year":"1979","journal-title":"Cognit Ther Res"},{"key":"R41-5-20210208","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/ajp.151.6.876","article-title":"Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder?","volume":"151","author":"Spiegel","year":"1994","journal-title":"Am J Psychiatry"},{"key":"R42-5-20210208","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1017\/S0033291700007248","article-title":"Double-blind procedure: An assessment in a study of lithium prophylaxis.","volume":"5","author":"Stallone","year":"1975","journal-title":"Psychol Med"},{"key":"R43-5-20210208","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0887-6185(02)00091-9","article-title":"Naturalistic manner of benzodiazepine use and cognitive behavioral therapy in panic disorder with agoraphobia.","volume":"16","author":"Westra","year":"2002","journal-title":"J Anxiety Disord"},{"key":"R44-5-20210208","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/archpsyc.1996.01830080041008","article-title":"Does brief dynamic psychotherapy reduce the relapse rate of panic disorder?","volume":"43","author":"Wiborg","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"R45-5-20210208","article-title":"Treatment of Panic Disorder: A Consensus Development Conference (pp 3\u201316).","author":"Wolfe","year":"1994"},{"key":"R46-5-20210208","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1176\/ajp.155.10.1446","article-title":"Efficient allocation of patients to treatment cells in clinical trials with more than two treatment conditions.","volume":"155","author":"Woods","year":"1998","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Nervous &amp; Mental Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005053-200807000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:40:05Z","timestamp":1786038005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005053-200807000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/nmd.0b013e31817cf6f7","relation":{},"ISSN":["0022-3018"],"issn-type":[{"value":"0022-3018","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}